Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Jun-Ichi Masuyama"'
Autor:
Somayeh Rezaeifard, Yuji Heike, Jun-Ichi Masuyama, Alireaz Rezvani, Reza Vojdani, Nasrollah Erfani
Publikováno v:
Iranian Journal of Allergy, Asthma and Immunology, Vol 20, Iss 2 (2021)
Natural killer (NK) cell therapy has proven to be a promising approach for the treatment of malignancies. Osaki method for ex-vivo autologous NK cell expansion has been recently introduced in Japan. To start clinical trial phase I at Shiraz Universit
Externí odkaz:
https://doaj.org/article/b51743f84a7c4e658838abf6fecdf667
Autor:
Nasrollah Erfani, Reza Vojdani, Alireaz Rezvani, Somayeh Rezaeifard, Jun-ichi Masuyama, yuji Heike
Publikováno v:
Iranian Journal of Allergy, Asthma and Immunology, Vol 20, Iss 2 (2021)
Natural killer (NK) cell therapy has proven to be a promising approach for the treatment of malignancies. Osaki method for ex-vivo autologous NK cell expansion has been recently introduced in Japan. To start clinical trial phase I at Shiraz Universit
Autor:
Rezaeifard, Somayeh, Yuji Heike, Jun-Ichi Masuyama, Rezvani, Alireza, Vojdani, Reza, Erfani, Nasrollah
Publikováno v:
Iranian Journal of Allergy, Asthma & Immunology; Mar2021, Vol. 20 Issue 2, p229-239, 11p
Publikováno v:
Cytotherapy. 18(1)
Background aims. This study developed a new method to expand CD3 − CD56 + natural killer (NK) cells from human peripheral blood mononuclear cells (PBMCs) without feeder cells for clinical trials. Methods. PBMCs from healthy subjects were co-stimula
Autor:
Seiji Minota, Yasunori Yamaguchi, Shuji Kaga, Yasunori Uemura, Toshiyuki Tanaka, Yoshiaki Sohma, Tetsuto Kobayashi, Kaori Horie, Hiroko Inazawa, Jun-Ichi Masuyama, Kumiko Kojima, Yumi Aoki, Isao Serizawa, Tomoko Watanabe
Publikováno v:
Clinical Immunology. 120:247-259
We previously reported that 4C8 monoclonal antibody (mAb) provides a costimulatory signal to human CD4+ T cells and consequently induces regulatory T (Treg) cells, which are hypo-responsive and suppress the polyclonal response of bystander CD4+ cells
Autor:
Seiji Minota, Masahiro Iwamoto, Sato H, Kimiaki Torikoe, Hitoaki Okazaki, Takeshi Kamimura, Hiroyuki Nara, Jun-Ichi Masuyama
Publikováno v:
Internal Medicine. 44:657-661
A 74-year-old woman with Sjögren's syndrome and chronic hepatitis C (CHC) was admitted to our hospital in October 2003 for treatment of diabetes mellitus. She had the past history of recurrent thrombocytopenia, which was proven to be due to peripher
Autor:
Kimiaki Torikoe, Yuzuru Mikami, Seiji Minota, Akiko Kageyama, Jun-Ichi Masuyama, Hitoaki Okazaki, Reiner M. Kroppenstedt, Yasuhiro Shibuya, Katsukiyo Yazawa, Masahiro Iwamoto
Publikováno v:
Journal of Clinical Microbiology. 42:2366-2371
Two different bacterial strains with different drug susceptibilities were isolated from the sputum and an inflammatory discharge from a swelling in the left thigh of a patient with rheumatoid arthritis. Both bacterial strains were provisionally assig
Autor:
Jun-ichi Masuyama, Seiji Minota, Hiroyuki Nara, Takeshi Kamimura, Yasuyuki Kamata, Kengo Haneda, Masahiro Iwamoto, Hitoaki Okazaki
Publikováno v:
Internal Medicine. 43:1201-1204
A 49-year-old Japanese man with rheumatoid arthritis acutely developed a skin eruption and severe non-productive cough seventeen days after the administration of leflunomide. Because all bacteriology findings were negative, steroid pulse-therapy was
Autor:
Takahisa Yamane, Jun-Ichi Masuyama, Yasutaka Aoyama, Kensuke Ohta, Seiichi Kitagawa, Kenichi Suzuki, Noriyuki Tatsumi, Masayuki Hino
Publikováno v:
Cytometry. 50:8-13
Background: A novel monoclonal antibody, anti-4C8, reacted with human peripheral lymphocytes and monocytes but not with neutrophils. In this study, we investigated whether the 4C8 antigen is expressed on human peripheral eosinophils. Methods: Express
Autor:
Shogo Kano, N. Satoh, Seiji Minota, Teruhiko Suzuki, Jun-Ichi Masuyama, Taku Yoshio, Akio Mimori, Hiroyuki Nara
Publikováno v:
Modern Rheumatology. 10:117-120
We report on five patients with dermatomyositis (DM) and cutaneous necrosis. Patients presented with classic DM skin eruptions, mild myositis, and a high incidence (4/5) of interstitial pneumonia. Cutaneous necrosis developed independently of steroid